Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

IL-33 Inhibitor Delivers in COPD Trials

(MedPage Today) -- A broad population of people with chronic obstructive pulmonary disease (COPD), current and former smokers alike, experienced fewer exacerbations taking a first-in-class biologic targeting interleukin (IL)-33, a pair of double...

IL-33 Inhibitor Delivers in COPD Trials

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 9 September →